Abacus Planning Group’s Zimmer Biomet ZBH Stock Holding History

Abacus Planning Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,472	Closed	-$214K	–	190
2019 Q4	$214K	Buy	+1,472	New	+$203K	0.1%	154

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Abacus Planning Group's ZBH Position: Q1 2020 in Review

Abacus Planning Group sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 1,472 shares — an estimated $214K sold.

Abacus Planning Group first reported a position in ZBH in Q4 2019 and held it in 1 quarter. The position peaked at $214K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

Abacus Planning Group reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
Abacus Planning Group sold 1,472 Zimmer Biomet shares in Q1 2020, an estimated $214K.
Abacus Planning Group first reported a position in Zimmer Biomet in Q4 2019 and held it in 1 quarter.
Abacus Planning Group's Zimmer Biomet position peaked at $214K in Q4 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Abacus Planning Group's 13F filing for Q1 2020, filed 30 Apr 2020.